Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annu... (36 in both type 2 diabetes and obesityap...)

HOME >> MEDICINE >> TECHNOLOGY

Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting

Date:10/25/2007

36 in both type 2 diabetes and obesity applications. The response by the scientific and medical attendees to both Genaera poster presentations was encouraging and supportive and we enthusiastically look forward to further exploring the potential of this unique and promising drug. Also important to note is that we are very encouraged by the initial Phase 2 MEDI-528 results to date as presented at the Chest Physicians Meeting in Chicago. MedImmune indicates that these results offer positive reasons to continue with the remainder of their Phase 2 program."

Genaera notes that both poster presentations are now available on the Company website at http://www.genaera.com.

About Trodusquemine

Trodusquemine (MSI-1436) is the first drug candidate that acts both centrally and peripherally to selectively inhibit the established and validated enzyme target, protein tyrosine phosphatase 1B (PTP-1B). The dual locations of MSI-1436 action make the drug a promising candidate for both type 2 diabetes and obesity. By inhibiting PTP-1B, trodusquemine has been shown to decrease appetite and normalize blood sugar as PTB-1B is central to both the insulin and leptin pathways. Based on this unique mechanism of action, trodusquemine has the potential to bridge the treatment for two of the most serious metabolic diseases, type 2 diabetes and obesity. In addition, trodusquemine has overcome selectivity concerns that other compounds that target PTP-1B have failed to overcome. Preclinical studies demonstrate that trodusquemine is a potent, highly selective and reversible inhibitor of PTP- 1B. In vitro kinetics demonstrate that trodusquemine is a reversible, allosteric, noncompetitive inhibitor of PTP-1B, binding to a site different from the catalytic site of PTP-1B. Data also demonstrate that trodusquemine can produce consistent, sustainable weight loss in a variety of animal models and appears to overcome metabolic readjustment
'/>"/>

SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
3. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
4. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
5. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
6. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
7. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
8. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
9. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
10. XTL Provides Update on Phase I Clinical Trial of XTL-2125
11. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age

Post Your Comments:

(Date:6/18/2013)... June 19, 2013 , ... disease (PD) patients as add-on to levodopa ... in motor symptoms in fluctuating PD patients as ... Newron Pharmaceuticals S.p.A. ("Newron"), a research and development ... and its partner Zambon S.p.A., a pharmaceutical company ...

(Date:6/18/2013)... 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit Breakers announced ... Module. The X3130, integrated with E-T-A,s double-pole ... appliance inlet module, rocker switch and resettable overcurrent ... allows design engineers to streamline the number of ... by 66 percent - and reduce the overall ...

(Date:6/18/2013)... June 18, 2013 Recent regulatory and budget challenges ... Education groups at large pharmaceutical companies to effectively educate ... effective use of their new products. With the pressure ... is crucial that these "Med Ed" groups ... To address the changes that are transforming the ...

Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2 Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3 Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4 Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5 Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6 Three-in-One X3130 Appliance Inlet Module 2 Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2

[0] Safinamide Phase III Study Results Presented at 2013 MDS Meeting [0] Three-in-One X3130 Appliance Inlet Module [0] Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints

... Dec. 14, 2010 The U.S. Food and Drug Administration ... children younger than 10 years can result in serious ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Tessalon, approved by the FDA ... than 10, may attract younger children because of the ...

... announces that a new market research report is ... Markets for Video, High-Tech and Integrated OT Equipment ... The European Markets for Video, High-Tech ... Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain ...

FDA Says Tessalon Liquid Cough Capsules Pose Risk for Young Children Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011

(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...

(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility ... using drugs while allowing them to continue drinking alcohol. ... Alternatives, believe that abstinence-only approaches force people to wait ... that this approach hurts instead of helping. It ... States need treatment for addiction but only 3 million ...

(Date:6/19/2013)... June 19, 2013 Many trying-to-conceive ... it medically necessary, according to a recent ... Health Journal. The results of this research confirm ... than a decade – that trying-to-conceive women would ... a healthy body weight. Fairhaven Health is a ...

(Date:6/19/2013)... UK-- New data, published today in Menopause ... are experiencing less sex, and less satisfying sex ... because they are considerably less likely to access ... vaginal atrophy1. , The first-of-its-kind study, called the ... (CLOSER) study, showed that British post-menopausal women with ...

(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Ultimate ... Children's Telethon, an 11.5-hour broadcast on WFLA News Channel ... has collected more than $84 million for All Children's ... 2013, event, themed "30 Years of Miracles," marked the ... hour, 18 UMA employees worked the phones during the ...

Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2 Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2 Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4 Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2 Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2 Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3

[0] Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers [0] Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment [0] Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies [0] British women 50 percent less likley to recieve treatment for common menopausal symptoms [0] Ultimate Medical Academy Rallies in Support of All Children's Hospital

... 14 Here are,highlights from the July issue ... publication as often as you wish. Reprinting is ... is required. Include the following,subscription information as your ... toll-free for subscription,information, 1-800-333-9037, extension 9PR1., Test ...

... their heads perfectly still while putting may be hampering their ... , The research appears in the July issue of the ... of kinesiology at McMaster University and a golfer himselfsays the ... golf wisdom. , "Jack Nicklaus says the premier technical cause ...

... Physicians Cited Concerns After Delays in Delivering Equipment, ... 14 Florida physicians,have written letters to Sen. ... new Medicare competitive bidding program for durable medical,equipment ... Lauderdale, and,eight other metropolitan areas in the U.S., ...

... 14 The American Heart,Association,s new national officers ... David A. Josserand, executive vice president and chief ... is national chairman of,the board. Josserand will be ... fund raising, and will preside over all Board,of ...

... Widespread ... of Incisionless NOTES Surgery, SAN CLEMENTE, Calif., July ... Horgan, M.D., director of the UC San Diego,Center for ... (EOS) to demonstrate a technique that allows for appendectomy,without ...

... increase in death, major complications , , MONDAY, July ... after heart surgery is essential, whether one is or ... The British report, published in Circulation , ... patients is linked to a fourfold increase in death ...

Cached Medicine News:Health News:July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts 2 Health News:July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts 3 Health News:July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts 4 Health News:When it comes to putting, Tiger and Nicklaus 2 Health News:Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge 2 Health News:Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge 3 Health News:Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge 4 Health News:Josserand and Gardner to Lead American Heart Association in 2008-09 2 Health News:Surgeons Use USGI Medical's EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference 2 Health News:Poor Blood Sugar Control After Heart Surgery Impacts Outcomes 2

July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts When it comes to putting, Tiger and Nicklaus Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge Josserand and Gardner to Lead American Heart Association in 2008-09 Surgeons Use USGI Medical's EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference Poor Blood Sugar Control After Heart Surgery Impacts Outcomes

... is a combination of a screw and a ... offered by resorbable pins for a hammertoe fixation ... easy to use! Drill and tap the proximal ... portion of the implant proximally. Press fit the ...

The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...

... ideal for excising soft tissue more efficiently than ... The serrated edge on the straight scissor helps ... within the jaws for more efficient resection.,The curved ... are the perfect tools for ACL stump removal, ...

... The Arthroscopy Scissor is ideal for excising soft ... debris in the joint. The serrated edge on ... well as hold tissue within the jaws for ... and right jaw curvatures, are the perfect tools ...

Medicine Products:

Weil-Carver™ Hammertoe Implant Shoulder Instrumentation System Scissor, Left Curved Tip, 3.4 mm Straight Shaft (a)Scissor, Serrated Tooth Straight Tip, 3.4 mm Straight Shaft (b)